Congratulations to Seung Kim as he has been elected to the Association of American Physicians.

The new device can continuously sense levels of virtually any protein or molecule in the blood. The researchers say it could be transformative for disease detection, patient monitoring and biomedical research.

Sun Kim, MD, MS, associate professor of endocrinology, was a principal investigator at Stanford for a recent randomized, placebo-controlled clinical trial of the drug canagliflozin, which is a sodium glucose co-transporter 2 inhibitor.

Chemistry Professor Carolyn Bertozzi has been named the Baker Family Director of Stanford ChEM-H, an interdisciplinary research institute launched in 2013 to bridge chemistry, engineering and medicine to improve human health.

Technology for treating type 1 diabetes is becoming easier to use, an especially beneficial change for teens and young adults, according to a recent study published in JAMA.